UNEVALUABLE THERAPY

UNEVALUABLE THERAPY was reported 26 times

UNEVALUABLE THERAPY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Catechol-O-Methyltransferase Inhibitor [EPC] 1 0.0002
1 Anti-anginal [EPC] 1 0.0001
2 Prostacyclin Receptor Agonist [EPC] 2 0.0001
3 Thiazide-like Diuretic [EPC] 1 0.0000
4 Folate Analog [EPC] 1 0.0000
5 Vitamin A [EPC] 1 0.0000
6 Interleukin-12 Antagonist [EPC] 2 0.0000
7 Interleukin-23 Antagonist [EPC] 2 0.0000
8 Nicotinic Acid [EPC] 1 0.0000
9 Antidote [EPC] 1 0.0000
10 HER2/neu Receptor Antagonist [EPC] 1 0.0000
11 Non-Standardized Food Allergenic Extract [EPC] 1 0.0000
12 Acetylcholine Release Inhibitor [EPC] 1 0.0000
13 Endothelin Receptor Antagonist [EPC] 2 0.0000
14 Antirheumatic Agent [EPC] 1 0.0000
15 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
16 Sulfonylurea [EPC] 1 0.0000
17 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
18 Factor Xa Inhibitor [EPC] 2 0.0000
19 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
20 GLP-1 Receptor Agonist [EPC] 3 0.0000
21 Vitamin D [EPC] 2 0.0000
22 Loop Diuretic [EPC] 3 0.0000
23 Aldosterone Antagonist [EPC] 1 0.0000
24 Janus Kinase Inhibitor [EPC] 1 0.0000
25 Vitamin B12 [EPC] 2 0.0000
26 RANK Ligand Inhibitor [EPC] 1 0.0000
27 Vitamin C [EPC] 2 0.0000
28 Opioid Agonist [EPC] 1 0.0000
29 Platinum-based Drug [EPC] 1 0.0000
30 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
31 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
32 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
33 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
34 Corticosteroid [EPC] 3 0.0000
35 Insulin Analog [EPC] 1 0.0000
36 Kinase Inhibitor [EPC] 1 0.0000
37 Platelet Aggregation Inhibitor [EPC] 1 0.0000
38 Tumor Necrosis Factor Blocker [EPC] 1 0.0000
39 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000